Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00291837
Status:
COMPLETED
Last Update Posted:
2010-02-26
First Post:
2006-02-14
Brief Title:
CT-2106 for the Second Line Treatment of Ovarian Cancer
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Organization Data
Organization:
CTI BioPharma
Class:
INDUSTRY
Study ID:
CAM203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CTI BioPharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None